ABSTRACT. Fetal glucose production has been observed in the chronically hypoglycemic, hypoinsulinemic (HH) fetal lamb. The purpose of this study was to test the hypothesis that induction of hepatic gluconeogenic enzymes occurs in this condition. The activities of both mitochondrial and cytosolic phosphoenolpyruvate carboxykinase (PEPCK), fructose-1,6-diphosphatase, and glucose-6-phosphatase, three key enzymes of gluconeogenesis, were determined in fetal sheep liver from H H lambs and controls (CONT). Pregnant ewes were maintained chronically hypoglycemic by continuous hyperinsulinemic clamps from approximately 80 d of gestational age (53% of gestation) for 6 wk. Fetuses (gestational age: H H = 136 -C 2.6, CONT = 133 2 3.7 d) were maintained chronically hypoglycemic [HH = 0.51 f 0.05 versus CONT = 1.22 f 0.11 mmol/L (9.2 f 1.0 versus 21.9 f 11.9 mg/dL)] and hypoinsulinemic (HH = 3.3 f 0.6 versus CONT = 12.0 f 2.2 pU/mL) and delivered by cesarean section after measurement of fetal glucose production rate. Hepatic cytosolic PEPCK was 6.0 f 1.4 nmol/min/mg protein in CONT and 19.7 f 2.5 in H H lamb (p < 0.05), whereas mitochondrial PEPCK was not different between the two groups. Neither fructose-1,6-dipbosphatase or glucose-6-phosphatase activities nor plasma glucagon levels were different between groups. These results suggest that chronic fetal hypoglycemia and hypoinsulinemia prematurely induce hepatic cytosolic PEPCK in the fetal lamb. The observed fetal glucose production in the H H fetal lamb may be due to gluconeogenesis. (Pediatr Res 33: 493-496, 1993) Abbreviations PEPCK, phosphoenolpyruvate carboxykinase G-6-Pase, glucose-6-phosphatase HH, hypoglycemic, hypoinsulinemic FDPase, fructose-1,6-diphosphatase Hepatic gluconeogenesis does not occur at significant rates in the unstressed fetal sheep (1). After birth, the newborn must
PEPCK was not different between the two groups. Neither fructose-1,6-dipbosphatase or glucose-6-phosphatase activities nor plasma glucagon levels were different between groups. These results suggest that chronic fetal hypoglycemia and hypoinsulinemia prematurely induce hepatic cytosolic PEPCK in the fetal lamb. The observed fetal glucose production in the H H fetal lamb may be due to gluconeogenesis. eventually develop gluconeogenic potential to maintain glucose homeostasis. Several studies have demonstrated that the development of hepatic gluconeogenesis is correlated with the appearance of cytosolic PEPCK (EC 4.1.1.32), the rate-limiting enzyme in gluconeogenesis (2) . Several investigators (2-4) have attempted to prematurely induce hepatic PEPCK specific activity and gluconeogenesis in vivo in the fetus. However, despite induction of hepatic cytosolic PEPCK specific activity and mRNA accumulation, significant fetal glucose production has rarely been demonstrated until very close to term, coincident with large increases in cortisol production by the fetal adrenal gland (2, 5) .
The chronically HH fetal lamb is a growth-retarded fetus that has been shown to have significant fetal glucose production (6) . Because the HH fetal lamb is growth-retarded and has little hepatic glycogen, this observed fetal glucose production may be due to gluconeogenesis (6) . Study of the gluconeogenic potential in such a model is important, as human infants with intrauterine growth retardation are frequently hypoglycemic, and limited gluconeogenesis has been suggested as one possible cause. We designed this study to determine the effect of chronic fetal hypoglycemia and hypoinsulinemia on the specific activities of PEPCK isoenzymes in the liver and kidney and the enzymes FDPase (D-fructose-l,6-bisphosphate I-phosphohydrolase, EC 3.1.3.1 1) and G-6-Pase (EC 3.1.3.9) in the liver. We hypothesized that hepatic cytosolic PEPCK specific activity (the rate-limiting enzyme of gluconeogenesis) would be prematurely increased in the H H fetal lamb.
MATERIALS AND METHODS
Materials. Chemicals were of highest grade available and were purchased from Sigma Chemical Co. (St. Louis, MO). I4C-NaHC03 (3.4 mCi/mmol) was from New England Nuclear (Boston, MA).
Animal preparation. Experiments were conducted in pregnant Columbia-Rambouillet ewes. The ewes were fasted for 2 d before surgery. An initial limited surgery was performed at approximately 80 d of gestation (53% of gestation) under i.v. pentobarbital (5.0 mg/kg) or ketamine (12 to 15 mg/kg) sedation. Two maternal catheters for infusion were placed into a femoral vein through a left groin incision, and a single catheter for sampling of arterial blood was placed into the femoral artery. At approximately 1 15 d of gestational age, a second surgery was performed under i.v. pentobarbital sedation ( 5 to 15 mg/kg) and spinal anesthesia (tetracaine HC16.0 mg in hypertonic glucose) or with i.v. ketamine (12 to 15 mg/kg) and intramuscular acetylpromethazine (I mg/kg) anesthesia. After a midline laparotomy, a catheter for sampling uterine venous blood was placed into the main uterine vein draining the pregnant uterine horn. Then, a standard hysterotomy was performed, and catheters for fetal infusions were placed into fetal femoral veins via hindlimb pedal veins. Additional catheters for fetal blood sampling were placed into the fetal abdominal aorta via a hindlimb pedal artery and, by a direct method, into the common umbilical vein via one of the two umbilical veins at the base of the umbilical cord. All catheters were tunneled S.C. through a flank incision on the ewe and kept within a plastic pouch attached to the ewe's skin. The catheters were flushed every day with heparinized 0.9% (wt/vol) sodium chloride (150 U heparin). Each ewe was allowed to recover postoperatively for 2 to 3 d until behavior, food intake, and water intake were normal. The ewes were kept in carts and given an ad libitum diet of alfalfa pellets, water, and mineral supplements. Intramuscular B-complex vitamins (Vedco, St. Joseph, MO) were given every week to the ewe. The ewes were housed in a room with the temperature controlled between 10 and 20°C. At least two sheep were always housed together for company (6, 7 Maternal arterial blood was sampled daily or twice daily for measurement of glucose and insulin concentration. The maternal arterial whole-blood glucose concentrations were used to adjust the insulin infusion rate to achieve a desired arterial whole-blood glucose concentration of approximately 1.4 mmol/L (25 mg/dL), representing an estimated reduction of 50% from normal. After fetal catheterization at 1 15 d gestation, it was observed that the maternal hypoglycemia also produced an approximately proportional decrease in fetal glucose and insulin concentrations (6) .
Before autopsy, a metabolic study was performed. The maternal insulin infusion to maintain maternal and fetal hypoglycemia at the chronically produced level was continued during the study. Antipyrine was infused by a primed, constant infusion method into the fetus to measure umbilical blood flow by the transplacental steady-state diffusion technique (8) . [U-14C]-glucose (332 mCi/mmol, ICN Biomedicals Inc., Costa Mesa, CA) was mixed with the antipyrine to deliver a primed constant infusion of tracer glucose to measure fetal glucose utilization (9) . After 120 min of infusion, blood was sampled simultaneously from the umbilical arterial and venous catheters at four times separated by 15-to 20-min intervals. This blood was used to measure blood concentrations of glucose, tracer glucose, and antipyrine, blood oxygen saturation and content, and plasma insulin and glucagon concentrations. After metabolic studies, the fetus was delivered by cesarean section with pentobarbital anesthesia (25 mg/kg). The ewe was then killed with a rapid i.v. infusion of CII euthanasia solution (Anthony Products, Acadia, CA). The fetal tissues were removed and the fetus was killed by exsanguination.
All aspects of the animal procurement (Nebekar Ranch, Santa Monica, CA), care, surgery, recovery, maintenance, study, and euthanasia were approved by the University of Colorado Health Sciences Center Institutional Animal Care and Use Committee.
Chemical and analytical methods. Whole-blood glucose concentration was measured by a glucose oxidase method (Sigma). Maternal and fetal plasma insulin concentrations were measured by a double antibody method using a kit from Cambridge Medical Diagnostics, Inc. (Billerica, MA) and ovine insulin standards from Eli Lilly (Indianapolis, IN). Interassay and intraassay variability was less than 8%. Maternal and fetal plasma glucagon were determined by RIA, specific for pancreatic glucagon, using a kit from ICN Biomedicals Inc. The intraassay variability was +8%, and the interassay variability was k 12.5 %.
Enzymatic analyses. Cytosolic and mitochondria1 fractions
were prepared from fresh liver and kidney tissue according to the method of Chang and Lane (10) . Mitochondria1 contamination of the cytosolic extract was routinely assayed by citrate synthase (1 1). PEPCK was assayed by the I4C-bicarbonate fixation assay of Chang and Lane (10 (13) with BSA as the standard. G-6-Pase was assayed on glucose-free crude liver extracts by the spectrophotometric assay of Gierow and Jergil (14) . Briefly, after homogenization in 0.35 M sucrose, 10 mM Tris, pH 7.4, the extract was centrifuged at 4000 x g at 4°C for 15 min. The endogenous glucose was removed from the supernatant by passage on a Sephadex G25 column (Pharmacia, Piscataway, NJ). Parallel spectrophotometric determinations were performed without the addition of glucose-6-phosphate to confirm the absence of glucose (14) . Results are expressed as nmol of product formed per min per mg of protein, assuming 2 nmole of NADH per nmol of product formed.
Statistics. Values are reported as mean f SEM. Differences among groups were analyzed by t test with significance at p < 0.05.
RESULTS
Chronic maternal hyperinsulinemic, hypoglycemic clamps resulted in a reduction of mean fetal glucose and insulin concentration compared with control animals ( Table 1 ). As shown in Table 1 , the HH fetal lambs were smaller when compared with control and had reduced liver weight reflecting the intrauterine growth retardation of the HH fetal lamb. There was a significant reduction in net umbilical glucose uptake in the HH fetal lambs and a trend toward a lower rate of glucose utilization ( Table 2) . (4) 3.06 + 0.28 (9) (mmol/L) Umbilical O2 uptake 329 + 17 (4) 361 + 17 (9) (wmol/kg/min) * All values are mean k SEM. Data available for only six of nine HH animals for glucose utilization and glucose production rate and four of six controls for 0 2 saturation, content, and uptake.
PEPCK. There was a decrease in the insu1in:glucagon molar ratio in the HH group. However, because this decrease was due solely to the decrease in plasma insulin in the HH animals, we were unable to separate the effect of hypoinsulinemia alone from that of the decrease in the insulin to glucagon ratio on cytosolic PEPCK. Evidence for the importance of the insu1in:glucagon ratio and fetal glucose production also comes from other studies in fetal sheep in which insulin-regulatable glucose production was observed in fetal sheep made hypoinsulinemic but hyperglucagonemic by streptozotocin (28) . In contrast, a much lower, almost negligible rate of glucose production was observed in fetal sheep made hypoinsulinemic but normoglucacgonemic by pancreatectomy (29) . Thus, in conditions with a low insulin to glucagon molar ratio, as in this model, fetal glucose production has been demonstrated (28) . Future studies will need to address the mechanism of this increase in PEPCK in the chronically HH fetal lamb. One such mechanism might involve regulation by corticosteroids. Dexamethasone has been shown to increase cytosolic PEPCK activity and mRNA in vivo and in vitro (30) (31) (32) , although this is controversial (25) . Because the HH fetal lamb may be a stressed animal, it is possible that the induction of cytosolic PEPCK in these animals is in part due to an increase in corticosteroid secretion. Indeed, studies by Townsend et al. (5) and Fowden et al. (33) have demonstrated the importance of cortisol in promoting the capacity for glucose production in the late gestation fetal sheep.
Previous studies in the rat have suggested that fetal hypoinsulinemia and hypoglycemia can induce G-6-Pase specific activity (22) ; but this has not been a consistent finding (2 1). Our data for G-6-Pase are similar to the first study of Gruppuso et al. (2 1 ) in fetal rats. They found no effect of chronic maternal hyperinsulinemia/hypoglycemia on fetal hepatic G-6-Pase levels. Indeed, the level of hepatic G-6-Pase in the late-gestation fetal lamb is close to the level in the postnatal lamb and is most likely sufficient for glucose release from the liver.
In conclusion, we have demonstrated the premature induction of hepatic cytosolic PEPCK in the HH fetal lamb. We suggest that the enzymatic requirements for fetal gluconeogenesis are present in the HH fetal lamb, and that gluconeogenesis may account for the fetal glucose production of the HH fetal lamb. The chronically HH fetal lamb may provide a model to study the ontologic regulation of hepatic cytosolic PEPCK and factors regulating fetal gluconeogenesis.
